Clinical Trial

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 19, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to learn about the long-term effects of HDR Brachytherapy in men with isolated local relapses after radical prostatectomy. The main question it aims to answer is: Does HDR Brachytherapy increase control rates and decreases complications compared with conventional External Irradiation? Participants will be asked to receive HDR brachytherapy as part of their regular medical care for isolated local relapses after radical prostatectomy
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-13.
Trial Details
NCT Number NCT06982469
Lead Sponsor Clinica Universidad de Navarra, Universidad de Navarra
Conditions Prostate Cancer, Prostatectomy, Local Recurrence of Malignant Tumor of Prostate, Radiotherapy; Complications, Brachytherapy
Enrollment 20 participants
Start Date 2020-05-05
Primary Completion 2026-05-01 (estimated)
Study Completion 2030-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-19